Documento, Documento-Fibrosis PulmonarReal-world therapeutic performance of pirfenidone for connective tissue disease-associated interstitial lung diseases Mariana Ruiz / 17/07/2025
Documento, Documento-Fibrosis HepáticaEvaluación no invasiva de pirfenidona de liberación prolongada en cirrosis hepática compensada. Estudio ODISEA, un ensayo aleatorizado. Mariana Ruiz / 03/07/2025
Documento, Documento-Fibrosis HepáticaNoninvasive Evaluation of Prolonged-Release Pirfenidone in Compensated Liver Cirrhosis. ODISEA Study, a Randomised Trial Mariana Ruiz / 17/06/2025
Documento, Documento-Fibrosis PulmonarClinical and economic burden of acute exacerbations of idiopathic pulmonary fibrosis: a prospective observational study in Spain (OASIS study) Mariana Ruiz / 15/05/2025
Documento, Documento-Fibrosis HepáticaIdentifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary Care Mariana Ruiz / 16/04/2025
Documento, Documento-Fibrosis PulmonarLong-term radiological and pulmonary function abnormalities at 3 years after COVID-19 hospitalisation: a longitudinal cohort study Mariana Ruiz / 25/03/2025
Documento, Documento-Fibrosis HepáticaGlobal prevalence of advanced fibrosis in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Mariana Ruiz / 18/02/2025
Documento, Documento-Fibrosis HepáticaAssociation between elevated fibrosis-4 index of liver fibrosis and risk of hemorrhagic stroke Mariana Ruiz / 20/12/2024
Documento, Documento-Fibrosis PulmonarAntifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study Mariana Ruiz / 20/12/2024
Documento, Documento-Fibrosis PulmonarPirfenidona LP en secuelas Post-COVID Mariana Ruiz / 31/10/2024
Documento, Documento-Fibrosis HepáticaPirfenidona de liberación prolongada restaura la expresión de miRNAs y la metilación de islas CpG en pacientes con hepatitis C con respuesta viral sostenida y fibrosis hepática residual Mariana Ruiz / 21/10/2024
Documento, Documento-Fibrosis PulmonarIncidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience Mariana Ruiz / 25/09/2024
